comparemela.com
  1. Home
  2. Live Updates
  3. Yukiko Sakakibara - Breaking News

Latest Breaking News On - Yukiko sakakibara - Page 1 : comparemela.com

Panitumumab vs Bevacizumab Added to Standard First-line Chemotherapy and Overall Survival Among Patients With RAS Wild-type, Left-Sided Metastatic Colorectal Cancer: A Randomized Clinical Trial | Colorectal Cancer | JAMA

This randomized clinical trial assesses the effect of adding panitumumab vs bevacizumab to standard first-line chemotherapy on overall survival among patients w

United statesEteläuomen läiSolasia pharmaMarko rehnTakayuki yoshinoMerck seronoLela creutzYakult honshaMerck biopharmaYukiko sakakibaraBayer yakuhinKaken pharmaLauren gallagherMichelle mcdermottEli lillyAsahi kasei

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.